Treat the brain and treat the periphery: Toward a holistic approach to major depressive disorder

Drug Discovery Today

Volumn 20, Issue 5, 2015, Pages 562-568

  Zheng, Xiao ^a,b   Zhang, Xueli ^b   Wang, Guangji ^c   Hao, Haiping ^c  

^a AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ANIMAL; BRAIN; DEPRESSIVE DISORDER, MAJOR; DRUG DESIGN; DRUG EFFECTS; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; PHILOSOPHY; PSYCHOLOGY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER, MAJOR; DRUG DESIGN; HOLISTIC HEALTH; HUMANS; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TREATMENT OUTCOME;

EID: 84937763027     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.03.015     Document Type: Review

References (66)

1. H.A. Whiteford Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 Lancet 382 2013 1575 1586
2. B. Breitenstein Are there meaningful biomarkers of treatment response for depression? Drug Discov. Today 19 2014 539 561
3. T. O'Dowd Depression and multimorbidity in psychiatry and primary care J. Clin. Psychiatry 75 2014 e1319 e1320
4. J. Haase, and E. Brown Integrating the monoamine, neurotrophin and cytokine hypotheses of depression - a central role for the serotonin transporter? Pharmacol. Ther. 147 2015 1 11
5. V. Krishnan, and E.J. Nestler The molecular neurobiology of depression Nature 455 2008 894 902
6. C. Nasca l-Acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors Proc. Natl. Acad. Sci. U. S. A. 110 2013 4804 4809
7. R.S. Duman, and G.K. Aghajanian Synaptic dysfunction in depression: potential therapeutic targets Science 338 2012 68 72
8. K. Barnett Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study Lancet 380 2012 37 43
9. J. Kornhuber The ceramide system as a novel antidepressant target Trends Pharmacol. Sci. 35 2014 293 304
10. E. Haroon Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior Neuropsychopharmacology 37 2012 137 162
11. I.A. Qureshi, and M.F. Mehler Towards a 'systems'-level understanding of the nervous system and its disorders Trends Neurosci. 36 2013 674 684
12. B.W. Penninx Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile BMC Med. 11 2013 129
13. R. Dantzer From inflammation to sickness and depression: when the immune system subjugates the brain Nat. Rev. Neurosci. 9 2008 46 56
14. R.H. McCusker, and K.W. Kelley Immune-neural connections: how the immune system's response to infectious agents influences behavior J. Exp. Biol. 216 2013 84 98
15. S. Keri Expression of Toll-like receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder Brain Behav. Immun. 40 2014 235 243
16. C.L. Raison A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers JAMA Psychiatry 70 2013 31 41
17. D. Mehta Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression Brain Behav. Immun. 31 2013 205 215
18. M. Iwata The inflammasome: pathways linking psychological stress, depression, and systemic illnesses Brain Behav. Immun. 31 2013 105 114
19. J.C. O'Connor Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin J. Neurosci. 29 2009 4200 4209
20. U. Krugel Antidepressant effects of TNF-alpha blockade in an animal model of depression J. Psychiatr. Res. 47 2013 611 616
21. J.F. Cryan, and T.G. Dinan Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour Nat. Rev. Neurosci. 13 2012 701 712
22. G.A. Rook, and C.A. Lowry The hygiene hypothesis and psychiatric disorders Trends Immunol. 29 2008 150 158
23. C. D'Mello P-selectin-mediated monocyte-cerebral endothelium adhesive interactions link peripheral organ inflammation to sickness behaviors J. Neurosci. 33 2013 14878 14888
24. J.A. Foster, and K.A. McVey Neufeld Gut-brain axis: how the microbiome influences anxiety and depression Trends Neurosci. 36 2013 305 312
25. C.J. Smith Probiotics normalize the gut-brain-microbiota axis in immunodeficient mice Am. J. Physiol. Gastrointest. Liver Physiol. 307 2014 G793 G802
26. G.A. Rook Can we vaccinate against depression? Drug Discov. Today 17 2012 451 458
27. E. Holmes Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk Cell Metab. 16 2012 559 564
28. G.A. Rook Microbiota, immunoregulatory old friends and psychiatric disorders Adv. Exp. Med. Biol. 817 2014 319 356
29. L. Zhao Targeting the human genome-microbiome axis for drug discovery: inspirations from global systems biology and traditional Chinese medicine J. Proteome Res. 11 2012 3509 3519
30. J. Xu Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula ISME J. 9 2015 552 562
31. M. Fadgyas-Stanculete The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations J. Mol. Psychiatry 2 2014 4
32. W.J. Lee, and K. Hase Gut microbiota-generated metabolites in animal health and disease Nat. Chem. Biol. 10 2014 416 424
33. C.L. Maynard Reciprocal interactions of the intestinal microbiota and immune system Nature 489 2012 231 241
34. D. Xu Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats Gastroenterology 146 2014 484 496
35. W. Beumer The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes J. Leukoc. Biol. 92 2012 959 975
36. E.S. Wohleb Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior J. Neurosci. 33 2013 13820 13833
37. A. Sawada Suppression of bone marrow-derived microglia in the amygdala improves anxiety-like behavior induced by chronic partial sciatic nerve ligation in mice Pain 155 2014 1762 1772
38. N.D. Powell Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via beta-adrenergic induction of myelopoiesis Proc. Natl. Acad. Sci. U. S. A. 110 2013 16574 16579
39. G.A. Rook Lymphocytes in neuroprotection, cognition and emotion: is intolerance really the answer? Brain Behav. Immun. 25 2011 591 601
40. A.H. Miller Depression and immunity: a role for T cells? Brain Behav. Immun. 24 2010 1 8
41. S.J. Kim CD4+CD25+ regulatory T cell depletion modulates anxiety and depression-like behaviors in mice PLOS ONE 7 2012 e42054
42. H. Himmerich Regulatory T cells increased while IL-1beta decreased during antidepressant therapy J. Psychiatr. Res. 44 2010 1052 1057
43. H. Cohen Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells J. Neurobiol. 66 2006 552 563
44. H. Kim Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression J. Clin. Invest. 122 2012 2940 2954
45. D. Zwilling Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration Cell 145 2011 863 874
46. R. Kozak Reduction of brain kynurenic acid improves cognitive function J. Neurosci. 34 2014 10592 10602
47. B.S. Diniz Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression Mol. Psychiatry 2014 76 10.1038/mp.2014
48. L. Giusti Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach Mol. Biosyst. 10 2014 1246 1254
49. H.D. Schmidt Functional biomarkers of depression: diagnosis, treatment, and pathophysiology Neuropsychopharmacology 36 2011 2375 2394
50. G.E. Hodes Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress Proc. Natl. Acad. Sci. U. S. A. 111 2014 16136 16141
51. M. Mapstone Plasma phospholipids identify antecedent memory impairment in older adults Nat. Med. 20 2014 415 418
52. P. Zheng A novel urinary metabolite signature for diagnosing major depressive disorder J. Proteome Res. 12 2013 5904 5911
53. J. Savitz Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder Neuropsychopharmacology 40 2015 463 471
54. S.K. Davies Effect of sleep deprivation on the human metabolome Proc. Natl. Acad. Sci. U. S. A. 111 2014 10761 10766
55. S. Leclercq Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity Proc. Natl. Acad. Sci. U. S. A. 111 2014 E4485 E4493
56. E.Y. Hsiao Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders Cell 155 2013 1451 1463
57. H. Wesseling A targeted multiplexed proteomic investigation identifies ketamine-induced changes in immune markers in rat serum and expression changes in protein kinases/phosphatases in rat brain J. Proteome Res. 14 2015 411 421
58. J. Jochems Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability Neuropsychopharmacology 39 2014 389 400
59. X. Zhang Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats PLOS ONE 7 2012 e42529
60. H. Hao Insights into drug discovery from natural medicines using reverse pharmacokinetics Trends Pharmacol. Sci. 35 2014 168 177
61. H. Liu Depression after myocardial infarction: TNF-alpha-induced alterations of the blood-brain barrier and its putative therapeutic implications Neurosci. Biobehav. Rev. 37 2013 561 572
62. F. Lamers Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression Mol. Psychiatry 18 2013 692 699
63. C.B. Zhu Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters Neuropsychopharmacology 35 2010 2510 2520
64. X. Cao Astrocyte-derived ATP modulates depressive-like behaviors Nat. Med. 19 2013 773 777
65. S.Y. Yau Physical exercise-induced hippocampal neurogenesis and antidepressant effects are mediated by the adipocyte hormone adiponectin Proc. Natl. Acad. Sci. U. S. A. 111 2014 15810 15815
66. L.Z. Agudelo Skeletal muscle PGC-1alpha1 modulates kynurenine metabolism and mediates resilience to stress-induced depression Cell 159 2014 33 45